GMP Ciprofloxacin HCl tablet 500mg use

Product Description

The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight.

The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course.

Treatment of infections due to certain bacteria (e.g. Pseudomonas aeruginosaAcinetobacter or Staphylococci) may require higher ciprofloxacin doses and co-administration with other appropriate antibacterial agents.

Treatment of some infections (e.g. pelvic inflammatory disease, intra-abdominal infections, infections in neutropenic patients and infections of bones and joints) may require co-administration with other appropriate antibacterial agents depending on the pathogens involved.

Adults

Indications

Daily dose in mg

Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin)

Infections of the lower respiratory tract

500 mg twice daily to 750 mg twice daily

7 to 14 days

Infections of the upper respiratory tract

Acute exacerbation of chronic sinusitis

500 mg twice daily to 750 mg twice daily

7 to 14 days

Chronic suppurative otitis media

500 mg twice daily to 750 mg twice daily

7 to 14 days

Malignant external otitis

750 mg twice daily

28 days up to 3 months

Urinary tract infections (see section 4.4)

Uncomplicated cystitis

250 mg twice daily to 500 mg twice daily

3 days

In pre-menopausal women, 500 mg single dose may be used

Complicated cystitis, Uncomplicated pyelonephritis

500 mg twice daily

7 days

Complicated pyelonephritis

500 mg twice daily to 750 mg twice daily

at least 10 days, it can be continued for longer than 21 days in some specific circumstances (such as abscesses)

Prostatitis

500 mg twice daily to 750 mg twice daily

2 to 4 weeks (acute) to 4 to 6 weeks (chronic)

Genital tract infections

Gonococcal uretritis and cervicitis

500 mg as a single dose

1 day (single dose)

Epididymo-orchitis and pelvic inflammatory diseases

500 mg twice daily to 750 mg twice daily

at least 14 days

Infections of the gastro-intestinal tract and intra-abdominal infections

Diarrhoea caused by bacterial pathogens including Shigella spp. other than Shigella dysenteriaetype 1 and empirical treatment of severe travellers' diarrhoea

500 mg twice daily

1 day

Diarrhoea caused by Shigella dysenteriae type 1

500 mg twice daily

5 days

Diarrhoea caused by Vibrio cholerae

500 mg twice daily

3 days

Typhoid fever

500 mg twice daily

7 days

Intra-abdominal infections due to Gram-negative bacteria

500 mg twice daily to 750 mg twice daily

5 to 14 days

Infections of the skin and soft tissue

500 mg twice daily to 750 mg twice daily

7 to 14 days

Bone and joint infections

500 mg twice daily to 750 mg twice daily

max. of 3 months

Neutropenic patients with fever that is suspected to be due to a bacterial infection

Ciprofloxacin should be co-administered with appropriate antibacterial agent(s) in accordance to official guidance.

500 mg twice daily to 750 mg twice daily

Therapy should be continued over the entire period of neutropenia

Prophylaxis of invasive infections due to Neisseria meningitidis

500 mg as a single dose

1 day (single dose)

Inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate.

Drug administration should begin as soon as possible after suspected or confirmed exposure.

500 mg twice daily

60 days from the confirmation of Bacillus anthracis exposure

Paediatric population

Indications

Daily dose in mg

Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin)

Cystic fibrosis

20 mg/kg body weight twice daily with a maximum of 750 mg per dose.

10 to 14 days

Complicated urinary tract infections and pyelonephritis

10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose.

10 to 21 days

Inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate. Drug administration should begin as soon as possible after suspected or confirmed exposure.

10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose.

60 days from the confirmation of Bacillus anthracis exposure

Other severe infections

20 mg/kg body weight twice daily with a maximum of 750 mg per dose.

According to the type of infections

Elderly patients

Elderly patients should receive a dose selected according to the severity of the infection and the patient's creatinine clearance.

Patients with renal and hepatic impairment

Recommended starting and maintenance doses for patients with impaired renal function:

Creatinine Clearance

[mL/min/1.73 m2]

Serum Creatinine

[µmol/L]

Oral Dose

[mg]

> 60

< 124

See Usual Dosage.

30-60

124 to 168

250-500 mg every 12 h

<30

>169

250-500 mg every 24 h

Patients on haemodialysis

>169

250-500 mg every 24 h

(after dialysis)

Patients on peritoneal dialysis

>169

250-500 mg every 24 h

In patients with impaired liver function, no dose adjustment is required.

Dosing in children with impaired renal and/or hepatic function has not been studied.

Method of administration

Tablets are to be swallowed unchewed with fluid. They can be taken independent of mealtimes. If taken on an empty stomach, the active substance is absorbed more rapidly. Ciprofloxacin tablets should not be taken with dairy products (e.g. milk, yoghurt) or mineral-fortified fruit -juice (e.g. calcium-fortified orange juice) (see section 4.5).

In severe cases or if the patient is unable to take tablets (e.g. patients on enteral nutrition), it is recommended to commence therapy with intravenous ciprofloxacin until a switch to oral administration is possible.

Contact Info

CONTACT US

NINGBO VOICE BIOCHEMIC CO. LTD

Address: 298 West Zhongshan Road.,Ningbo,Zhejiang

Contact Person: Medic Ren

Phone:86-574-87330957

Fax:86-574-87330957

Full name Contact Phone Content
点击刷新验证码